Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

NGNE Relative to the S&P 500

NGNE Relative to the Sector

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Neurogene Inc. (NASD:NGNE) seasonal charts above shows that a Buy Date of November 20 and a Sell Date of February 8 has resulted in a geometric average return of 29.33% above the benchmark rate of the S&P 500 Total Return Index over the past 11 years. This seasonal timeframe has shown positive results compared to the benchmark in 9 of those periods. This is a very good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 11 years by an average of 55.83% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Neurogene, Inc. is a clinical-stage biotechnology company, which engages in the development of product portfolio of genetic medicines for rare neurological diseases. The company was founded in May 2007 and is headquartered in New York, NY.

To download NGNE seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: NGNE